Paul Treacy, SVP, Technical Operations at Jazz Pharmaceuticals plc (JAZZ), sold 2,120 shares at $135.41 ($287K) on 2019-03-06, disclosed to the SEC on 2019-03-07.
Seasonal sale ($287k) by SVP, Technical Operations — this insider has traded JAZZ in March in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $135.41 | 471 | $64K | 22.2% |
| 2 | $135.41 | 471 | $64K | 22.2% |
| 3 | $135.41 | 589 | $80K | 27.8% |
| 4 | $135.41 | 589 | $80K | 27.8% |
| Total | $135.41 avg | 2,120 | $287K | 100% |
| Filing → |
| JAZZ | SELL | 2018-08-13 | $462K | — | Filing → |
| JAZZ | SELL | 2018-03-07 | $168K | — | Filing → |
| JAZZ | SELL | 2018-03-05 | $196K | — | Filing → |